ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

MNPR Company Profile and Key Details

NASDAQ : MNPR

Monopar Therapeutics Inc.

$38.53

5.1+15.26%

At Close 4:00 PM

64.5

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

MNPR Stock Price Chart

Stock Price Today

Monopar Therapeutics Inc. (MNPR) stock surged +15.26%, trading at $38.53 on NASDAQ, up from the previous close of $33.43. The stock opened at $31.70, fluctuating between $34.24 and $41.68 in the recent session.

Stock Snapshot

33.43

Prev. Close

31.7

Open

235.52M

Market Cap

6.11M

Number of Shares

34.24

Day Low

41.675

Day High

-19.46

P/E Ratio

64.37%

Free Float in %

-1.98

EPS (TTM)

0.37

Book Value

-0.53

Cash Flow per Share

71.26K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2025	31.70	42.00	31.70	38.53	71.26K
Apr 01, 2025	34.96	36.46	31.79	33.43	36.88K
Mar 31, 2025	38.72	39.51	32.00	36.41	43.39K
Mar 28, 2025	40.21	42.68	37.25	40.33	17.68K
Mar 27, 2025	37.51	43.00	36.80	41.39	25.54K
Mar 26, 2025	37.99	38.23	36.86	38.10	19.9K
Mar 25, 2025	36.37	38.49	35.63	37.58	15.75K
Mar 24, 2025	42.00	42.83	34.13	37.60	24.1K
Mar 21, 2025	46.00	46.00	35.46	40.00	59.5K
Mar 20, 2025	38.09	47.83	38.09	44.74	47.87K
Mar 19, 2025	36.56	42.96	34.50	39.10	46.2K
Mar 18, 2025	34.00	35.35	31.30	34.37	31.27K
Mar 17, 2025	29.57	34.88	29.53	34.23	22.9K
Mar 14, 2025	29.49	30.99	29.49	29.75	20.43K
Mar 13, 2025	31.35	31.90	29.49	29.49	33.28K
Mar 12, 2025	30.51	34.11	30.20	30.90	17.8K
Mar 11, 2025	27.34	31.29	27.34	29.28	32.7K
Mar 10, 2025	28.65	29.87	27.05	27.95	30.43K
Mar 07, 2025	30.59	30.86	27.81	28.44	41.3K
Mar 06, 2025	29.42	31.69	28.65	30.93	26.6K

Contact Details

Wilmette, IL 60091

United States

Website: https://www.monopartx.comContact: 847 388 0349

About Company

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal cancer. The company also engages in developing Camsirubicin, an analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; MNPR-101, a urokinase plasminogen activator receptor targeted antibody for the treatment of various cancers; MNPR-101 RIT, a radioimmunotherapeutic based on MNPR-101 for the potential treatment of cancer and severe COVID-19; and MNPR-202, an analog of camsirubicin to potentially treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations with the Grupo Español de Investigación en Sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; NorthStar Medical Radioisotopes, LLC to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was incorporated in 2014 and is headquartered in Wilmette, Illinois.

Frequently Asked Questions

What is the current Monopar Therapeutics Inc. (MNPR) stock price?

Monopar Therapeutics Inc. (NASDAQ: MNPR) stock price is $38.53 in the last trading session. During the trading session, MNPR stock reached the peak price of $41.68 while $34.24 was the lowest point it dropped to. The percentage change in MNPR stock occurred in the recent session was 15.26% while the dollar amount for the price change in MNPR stock was $5.10.

MNPR's industry and sector of operation?

The NASDAQ listed MNPR is part of Biotechnology industry that operates in the broader Healthcare sector. Monopar Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MNPR?

Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc
Co-Founder, Chief Executive Officer, Pres & Director
Ms. Kim R. Tsuchimoto CPA
Chief Financial Officer, Sec., Treasurer & Director
Mr. Andrew J. Cittadine M.B.A.
Chief Operating Officer
Dr. Patrice P. Rioux M.D., Ph.D.
Acting Chief Medical Officer

How MNPR did perform over past 52-week?

MNPR's closing price is 2,140.12% higher than its 52-week low of $1.72 where as its distance from 52-week high of $54.30 is -29.04%.

How many employees does MNPR have?

Number of MNPR employees currently stands at 9.

Link for MNPR official website?

Official Website of MNPR is: https://www.monopartx.com

How do I contact MNPR?

MNPR could be contacted at phone 847 388 0349 and can also be accessed through its website. MNPR operates from 1000 Skokie Boulevard, Wilmette, IL 60091, United States.

How many shares of MNPR are traded daily?

MNPR stock volume for the day was 71.26K shares. The average number of MNPR shares traded daily for last 3 months was 51.78K.

What is the market cap of MNPR currently?

The market value of MNPR currently stands at $235.52M with its latest stock price at $38.53 and 6.11M of its shares outstanding.

Employees	9
Beta	1.19
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology